LabTurbo Biotech Corporation(TW:7725)
NT$21.000.00 (0.00%)
TW:7725
LabTurbo Biotech Corporation financials statements
NT$21.00
At close:0.00 (0.00%)
LabTurbo Biotech Corporation (7725) Ratios
LabTurbo Biotech Corporation Ratios
TW:7725's free cash flow for Q2 2026 was NT$-88.06M. For the 2026 fiscal year, TW:7725's free cash flow was decreased by NT$-1.28M and operating cash flow was NT$-86.78M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 18.21 | 20.74 | 18.90 | 6.43 | 4.18 |
| Quick Ratio | 16.86 | 18.70 | 17.32 | 5.92 | 3.84 |
| Cash Ratio | 6.67 | 3.63 | 5.76 | 3.42 | 2.38 |
| Solvency Ratio | -1.26 | 0.83 | -0.27 | 2.85 | 1.57 |
| Operating Cash Flow Ratio | -1.68 | -2.49 | -2.93 | 4.13 | 1.00 |
| Short-Term Operating Cash Flow Coverage | -11.19 | 0.00 | -256.58 | 71.11 | 45.91 |
| Net Current Asset Value | NT$ 820.92M | NT$ 927.02M | NT$ 899.54M | NT$ 1.10B | NT$ 760.61M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.02 | 0.01 | 0.02 | 0.04 |
| Debt-to-Equity Ratio | 0.02 | 0.02 | 0.01 | 0.03 | 0.05 |
| Debt-to-Capital Ratio | 0.02 | 0.02 | 0.01 | 0.03 | 0.05 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.04 |
| Financial Leverage Ratio | 1.06 | 1.06 | 1.05 | 1.16 | 1.29 |
| Debt Service Coverage Ratio | -17.61 | 120.91 | -23.91 | 54.10 | 76.20 |
| Interest Coverage Ratio | -401.14 | -375.54 | -1057.70 | 1451.62 | 804.68 |
| Debt to Market Cap | 0.01 | 0.00 | 0.00 | 0.02 | 0.03 |
| Interest Debt Per Share | 0.45 | 0.59 | 0.23 | 0.89 | 1.19 |
| Net Debt to EBITDA | 2.12 | -2.75 | 31.93 | -0.78 | -0.92 |
| Profitability Margins | |||||
| Gross Profit Margin | -17.74% | 23.33% | 16.55% | 74.17% | 69.88% |
| EBIT Margin | -238.44% | 4.99% | -29.27% | 61.34% | 59.16% |
| EBITDA Margin | -181.36% | 73.35% | -4.71% | 64.45% | 61.22% |
| Operating Profit Margin | -238.44% | -250.10% | -95.03% | 59.49% | 59.64% |
| Pretax Profit Margin | -173.81% | 10.59% | -29.36% | 61.29% | 59.08% |
| Net Profit Margin | -166.36% | 17.76% | -34.21% | 47.89% | 46.81% |
| Continuous Operations Profit Margin | -166.36% | 17.76% | -34.21% | 47.89% | 46.81% |
| Net Income Per EBT | 95.71% | 167.72% | 116.50% | 78.13% | 79.23% |
| EBT Per EBIT | 72.90% | -4.23% | 30.90% | 103.04% | 99.06% |
| Return on Assets (ROA) | -10.65% | 0.93% | -4.59% | 36.18% | 33.59% |
| Return on Equity (ROE) | -11.28% | 0.99% | -4.82% | 41.84% | 43.23% |
| Return on Capital Employed (ROCE) | -15.89% | -13.61% | -13.23% | 50.93% | 52.61% |
| Return on Invested Capital (ROIC) | -15.11% | -13.54% | -13.20% | 39.31% | 41.38% |
| Return on Tangible Assets | -10.99% | 0.96% | -4.84% | 37.84% | 35.60% |
| Earnings Yield | -10.58% | 1.04% | -3.80% | 33.34% | 25.59% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.30 | 4.82 | 11.60 | 11.20 | 2.70 |
| Payables Turnover | 11.25 | 7.52 | 27.64 | 10.81 | 3.13 |
| Inventory Turnover | 1.41 | 0.57 | 1.95 | 3.25 | 3.38 |
| Fixed Asset Turnover | 0.41 | 0.32 | 0.83 | 5.60 | 4.73 |
| Asset Turnover | 0.06 | 0.05 | 0.13 | 0.76 | 0.72 |
| Working Capital Turnover Ratio | 0.09 | 0.08 | 0.18 | 1.38 | 0.00 |
| Cash Conversion Cycle | 277.25 | 669.67 | 205.63 | 111.24 | 126.21 |
| Days of Sales Outstanding | 49.99 | 75.65 | 31.47 | 32.58 | 134.98 |
| Days of Inventory Outstanding | 259.72 | 642.54 | 187.37 | 112.42 | 107.94 |
| Days of Payables Outstanding | 32.46 | 48.51 | 13.21 | 33.76 | 116.71 |
| Operating Cycle | 309.70 | 718.19 | 218.84 | 145.00 | 242.92 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.71 | -2.49 | -3.09 | 17.82 | 5.69 |
| Free Cash Flow Per Share | -1.74 | -2.90 | -3.64 | 16.58 | 2.92 |
| Dividend Paid and CapEx Coverage Ratio | -5.27 | -2.74 | -0.87 | 4.20 | 1.78 |
| Capital Expenditure Coverage Ratio | -67.81 | -6.06 | -5.60 | 14.37 | 2.06 |
| Operating Cash Flow Coverage Ratio | -3.92 | -4.28 | -13.76 | 20.28 | 4.85 |
| Operating Cash Flow to Sales Ratio | -1.04 | -1.65 | -0.80 | 0.64 | 0.26 |
| Free Cash Flow Yield | -6.70% | -11.30% | -10.41% | 41.56% | 7.32% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -9.45 | 95.19 | -26.32 | 3.00 | 3.91 |
| Price-to-Sales (P/S) Ratio | 15.73 | 17.04 | 9.00 | 1.44 | 1.83 |
| Price-to-Book (P/B) Ratio | 1.07 | 0.95 | 1.27 | 1.26 | 1.69 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -14.92 | -8.85 | -9.60 | 2.41 | 13.65 |
| Price-to-Operating Cash Flow Ratio | -15.14 | -10.31 | -11.32 | 2.24 | 7.01 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | -0.79 | 0.24 | 0.10 | 0.00 |
| Enterprise Value Multiple | -6.55 | 20.47 | -159.04 | 1.45 | 2.07 |
| Enterprise Value | 938.65M | 1.10B | 1.41B | 1.26B | 1.24B |
| EV to EBITDA | -6.55 | 20.47 | -159.04 | 1.45 | 2.07 |
| EV to Sales | 11.87 | 15.02 | 7.50 | 0.94 | 1.27 |
| EV to Free Cash Flow | -11.26 | -7.80 | -8.00 | 1.57 | 9.45 |
| EV to Operating Cash Flow | -11.43 | -9.09 | -9.43 | 1.46 | 4.85 |
| Tangible Book Value Per Share | 23.51 | 26.25 | 26.14 | 30.18 | 21.91 |
| Shareholders’ Equity Per Share | 24.30 | 27.15 | 27.61 | 31.79 | 23.63 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.04 | -0.68 | -0.17 | 0.22 | 0.21 |
| Revenue Per Share | 1.65 | 1.51 | 3.89 | 27.77 | 21.82 |
| Net Income Per Share | -2.74 | 0.27 | -1.33 | 13.30 | 10.21 |
| Tax Burden | 0.96 | 1.68 | 1.17 | 0.78 | 0.79 |
| Interest Burden | 0.73 | 2.12 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.93 | 1.16 | 0.44 | 0.05 | 0.03 |
| SG&A to Revenue | 0.86 | 1.57 | 0.68 | 0.10 | 0.07 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.62 | -15.60 | 2.71 | 1.34 | 0.44 |
Currency in TWD
